InsidersTradesSigma
Track the SYNTA PHARMACEUTICALS CORP share price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €48m. The latest transaction was filed on 5 January 2016 (Attribution). Among the most active insiders: Morenstein Scott D. The full history is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
SYNTA PHARMACEUTICALS CORP is a biopharmaceutical company focused on developing treatments for cancer. It is listed on the NASDAQ under the ticker SYTA.